Not another raw report. A clear path from evidence to action.
Evimple turns pharma opportunities into structured briefs with validated risks, partner strategy, go/no-go recommendations, and clear next steps.
What every opportunity brief includes
Each brief is designed to be forwarded internally: recommendation, evidence, risks, partner logic, and one clear next step.
Go/no-go recommendation
A clear pursue, pause, or reject recommendation for the molecule, product, licensing target, or partner search.
Opportunity score
Market attractiveness, portfolio fit, patent and FTO risk, regulatory complexity, and partner availability in one view.
Evidence and risks
Medical, competitive, patent, regulatory, and market evidence with explicit uncertainty flags and traceable sources.
Partner strategy
Recommended CDMO, CMO, CRO, supplier, analytical lab, or licensing partner profile with shortlist logic and next action.
Traceable sources - Human review - Partner network
Opportunity assessment built on verifiable sources
Patent & IP data
Major patent offices and freedom-to-operate sources, updated continuously.
Regulatory filings
FDA, EMA, and key agencies across major markets - requirements and status.
Scientific literature
Relevant medical and scientific sources to support development and positioning.
Corporate & commercial
Company data, pipelines, and commercial context for partnership decisions.
Why Evimple opportunity briefs
Your expertise is amplified. We handle evidence gathering, partner discovery, and structuring so your team can focus on interpretation, pressure-testing assumptions, and making recommendations that hold up. Briefs do not replace your judgment - they give you a consistent base so you can move faster from insight to action.
- One workspace: run opportunity assessment, licensing search, and partner discovery without switching tools or copying data.
- Structured deliverables your business development, portfolio, strategy, and licensing teams can review, refine, and present to stakeholders.
- Built for decisions that face scrutiny - traceable sources and clear narratives.
Get a walkthrough tailored to your use case
Whether you need product assessment, partner search, portfolio expansion, or licensing opportunity discovery - we'll show you the platform with your scenario in mind.
Book Demo